30
2
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T6906 |
Tamoxifen
ICI 46474,他莫昔芬,Z-Tamoxifen,trans-Tamoxifen,ICI47699 |
Apoptosis; Estrogen Receptor/ERR; HSP; Estrogen/progestogen Receptor; Autophagy | Apoptosis; Autophagy; Cytoskeletal Signaling; Endocrinology/Hormones; Metabolism |
Tamoxifen (ICI47699) 是一种雌激素受体调节剂 (SERM),具有选择性和口服有效性。Tamoxifen 对雌激素具有抑制活性 (如乳腺细胞) 和激活活性 (如骨、肝和子宫细胞)。 | |||
T13076 |
Tamoxifen-d5
ICI 47699-d5,(Z)-Tamoxifen-d5,trans-Tamoxifen-d5 |
HSP | Cytoskeletal Signaling; Metabolism |
Tamoxifen-d5 is a deuterium labeled Tamoxifen. Tamoxifen is a selective modulator of estrogen receptor (SERM). Tamoxifen is a potent activator of Hsp90 and enhances the Hsp90 molecular chaperone ATPase activity. | |||
T28919 |
Tamoxifen analog II
Tamoxifen analog III |
||
Tamoxifen analog II is a potent growth inhibitor. Tamoxifen analog II displays activity against various cancer cell lines. | |||
T0835 |
Tamoxifen Citrate
Tamoxifen Z-isomer citrate,ICI 46474,ICI 46474 Citrate,枸橼酸他莫昔芬,他莫昔芬柠檬酸盐 |
Apoptosis; Estrogen Receptor/ERR; HSP; Estrogen/progestogen Receptor; Autophagy | Apoptosis; Autophagy; Cytoskeletal Signaling; Endocrinology/Hormones; Metabolism |
Tamoxifen Citrate 是一种口服有效的,选择性雌激素受体调节剂,可阻断乳腺细胞中的雌激素作用,并可激活如骨骼、肝脏和子宫细胞中的雌激素活性。它是 Hsp90激活剂,可增强 Hsp90 分子伴侣 ATPase 的活性,可激活自噬和诱导凋亡。 | |||
T22512 |
4’-hydroxy Tamoxifen
|
Others | Others |
It is a metabolite of tamoxifen and an estrogen receptor modulator. | |||
T4281 |
Endoxifen
(E/Z)-N-desmethyl-4-hydroxy Tamoxifen,N-去甲基-4-羟基-,(E/Z)-Endoxifen |
Estrogen Receptor/ERR; Aromatase; Estrogen/progestogen Receptor; Parasite; Drug Metabolite | Endocrinology/Hormones; Metabolism; Microbiology/Virology |
Endoxifen ((E/Z)-Endoxifen) 是 Tamoxifen 的关键活性代谢物,能抑制芳香酶的活性,与雌激素受体有较高的亲和力和特异性。它有潜力研究乳腺癌。 | |||
T4420 |
4-Hydroxytamoxifen
ICI 79280,(Z)-4-hydroxy Tamoxifen,4-羟基他莫昔芬,trans-4-Hydroxytamoxifen |
Estrogen Receptor/ERR; Estrogen/progestogen Receptor | Endocrinology/Hormones |
4-Hydroxytamoxifen (ICI 79280) 是 Tamoxifen 的活性代谢产物,是一种雌激素受体调节剂 (SERM),具有选择性和口服有效性。4-Hydroxytamoxifen 具有抗肿瘤活性,可用于乳腺癌的研究。 | |||
T31262 |
Deamino-hydroxytamoxifen
Tamoxifen-ol,Tamoxifen metabolite Y |
||
Tamoxifen is a medication that is used to prevent breast cancer patients. | |||
T19192 |
α-Hydroxytamoxifen
α-OHTAM,(E)-α-Hydroxy tamoxifen |
Others | Others |
α-Hydroxytamoxifen is a metabolite of tamoxifen. It reacts with DNA and causes the formation of DNA adducts. | |||
T8984 |
FLTX1
|
Estrogen Receptor/ERR; Estrogen/progestogen Receptor | Endocrinology/Hormones |
FLTX1 is a fluorescent derivative of Tamoxifen, designed to efficiently target and label intracellular Tamoxifen-binding sites (estrogen receptors) both under permeabilized and non-permeabilized conditions. Additionally, FLTX1 demonstrates strong antiestrogenic activity in breast cancer cells, resembling the potent antiestrogenic properties of Tamoxifen. Notably, FLTX1 does not exhibit any estrogenic agonistic effect on the uterus. | |||
T12148 |
N-Desmethyltamoxifen hydrochloride
|
Estrogen Receptor/ERR; Endogenous Metabolite; PKC | Chromatin/Epigenetic; Cytoskeletal Signaling; Endocrinology/Hormones; Metabolism |
N-Desmethyltamoxifen hydrochloride 是 Tamoxifen 在人体内主要的三苯氧胺代谢物。它是蛋白激酶 C 抑制剂,也是人体 AML 细胞神经酰胺代谢的有效调节因子,可限制神经酰胺糖基化、水解和鞘氨醇磷酸化。 | |||
T6743 |
(E/Z)-4-Hydroxytamoxifen
4-羟基他莫昔芬,(E/Z)-4-羟基他莫昔芬,Afimoxifene,4-Hydroxytamoxifen |
Estrogen Receptor/ERR; Estrogen/progestogen Receptor | Endocrinology/Hormones |
(E/Z)-4-Hydroxytamoxifen (Afimoxifene) 是 tamoxifen 的活性代谢物和选择性雌激素受体(ER)调节剂,广泛用于乳腺癌的治疗和化学预防治疗。 | |||
T12148L |
N-Desmethyltamoxifen
|
Others | Others |
N-Desmethyltamoxifen, the principal metabolite of tamoxifen in humans, serves as an efficacious modulator of ceramide metabolism within human AML cells by inhibiting ceramide glycosylation, hydrolysis, and sphingosine phosphorylation. Although it demonstrates weak antiestrogenic properties, it acts as a protein kinase C (PKC) inhibitor with a potency ten times greater than that of tamoxifen. | |||
T15186 |
(E)-4-Hydroxytamoxifen
|
Others | Others |
(E)-4-Hydroxytamoxifen is a less active isomer of (Z)-4-hydroxytamoxifen and also is an estrogen receptor modulator. | |||
T2280 |
Endoxifen (Z-isomer)
Z-因多昔芬,Endoxifen Z-isomer,4-[(1E)-1-{4-[2-(甲基氨基)乙氧基]苯基}-2-苯基-1-丁烯-1-基]苯酚 |
Estrogen Receptor/ERR; EGFR; Potassium Channel; Estrogen/progestogen Receptor; HER | Angiogenesis; Endocrinology/Hormones; JAK/STAT signaling; Membrane transporter/Ion channel; Tyrosine Kinase/Adaptors |
Endoxifen Z-isomer (EDX)是 Tamoxifen 重要的代谢产物,在表达 ERα的乳腺癌细胞中发挥抗雌激素作用。它以浓度依赖的方式抑制 hERG, IC50值为1.6μM。 | |||
T15249 |
Estrogen receptor modulator 1
|
Estrogen Receptor/ERR | Endocrinology/Hormones |
Estrogen receptor modulator 1 是一种有效的、具有口服活性的、选择性雌激素受体(estrogen receptor)调节剂 (SERM),其 pIC50为 0.46。它能够诱导 Tamoxifen 耐药、激素非依赖性异种移植瘤的消退。 | |||
T35973 |
Cholesterol-5α,6α-epoxide
Epoxycholesterol,5α,6α-epoxy Cholestanol,NSC 18176 |
Others | Others |
Cholesterol-5α,6α-epoxide (Epoxycholesterol) 是胆固醇氧化产生的代谢产物。 在应用他莫昔芬和 PBPE 后,5α,6α-环氧胆甾烷醇通过与 LXRβ 结合诱导三酰甘油生物合成。 | |||
T6827L |
Endoxifen hydrochloride
|
||
Endoxifen hydrochloride,Tamoxifen的主要活性代谢产物,具备较高的对雌激素受体(estrogen receptor)的亲和力和特异性,并能抑制芳香酶活性。它在乳腺癌研究中表现出潜在应用价值。 | |||
T11098 |
Droloxifene
3-Hydroxytamoxifen |
Estrogen Receptor/ERR | Endocrinology/Hormones |
Droloxifene (3-Hydroxytamoxifen),Tamoxifen 衍生物,是一种具有口服活性和选择性的雌激素受体 (estrogen receptor) 调节剂。Droloxifene 具有抗雌激素和抗植入作用。Droloxifene 诱导 MCF-7 细胞 p53 表达及凋亡。Droloxifene 预防去卵巢大鼠骨丢失。 | |||
T29179 | YM-01 Tosylate | ||
YM-01 Tosylate, a potent antitumor agent, selectively targets cancer cells and overcoming tamoxifen resistance. | |||
T34326 |
Ridaifen-B
RidaifenB |
||
Ridaifen-B, a tamoxifen derivative, works by inducing independent autophagy of Bcl-2, without estrogen receptor involvement. | |||
T33876 |
panomifene
GYKI13504,GYKI 13504,EGIS5650,EGIS-5650,EGIS 5650,GYKI-13504 |
||
Panomiphene (Gyki-13504, EGIS-5650) is an anti-estrogen drug that is a tamoxifen (TMX) analogue. | |||
T6827 |
Endoxifen Z-isomer hydrochloride
Endoxifen HCl,Z-因多昔芬盐酸盐 |
Estrogen Receptor/ERR; Potassium Channel; Estrogen/progestogen Receptor; HER | Angiogenesis; Endocrinology/Hormones; JAK/STAT signaling; Membrane transporter/Ion channel; Tyrosine Kinase/Adaptors |
Endoxifen Z-isomer hydrochloride (Endoxifen HCl) 是Tamoxifen 最重要的代谢产物, 在表达ERα的乳腺癌细胞中发挥抗雌激素作用, Endoxifen HCl 以浓度依赖的方式抑制hERG, IC50值为1.6μM。 | |||
T3645 |
Endoxifen E-isomer hydrochloride
E-Endoxifen hydrochloride |
Estrogen Receptor/ERR; Estrogen/progestogen Receptor | Endocrinology/Hormones |
Endoxifen E-isomer hydrochloride (E-Endoxifen hydrochloride) 是 Endoxifen 的 E-异构体,是 Endoxifen Z-isomer 原料中主要的杂质,具有抗雌激素作用。 | |||
T71578 | Endoxifen mesylate | ||
Endoxifen, also known as N-desmethyl-4-hydroxytamoxifen, is a chemical that is under development for estrogen receptor-positive breast cancer. It is also being evaluated as an antipsychotic for treatment of mania and other psychotic disorders. Endoxifen is a nonsteroidal selective estrogen receptor modulator (SERM) of the triphenylethylene group. It is an active metabolite of tamoxifen and has been found to be effective in patients that have failed previous hormonal therapies (tamoxifen, aromat... | |||
T70013 |
Pipendoxifene
|
||
Pipendoxifene, also known as ERA-923, is a new antiestrogen with potential anticancer activity. ERA-923 potently inhibits estrogen binding to ER-alpha (IC50 = 14 nM). In ER-alpha-positive human MCF-7 breast carcinoma cells, ERA-923 inhibits estrogen-stimulated growth (IC50 = 0.2 nM) associated with cytostasis. In vitro, a MCF-7 variant with inherent resistance to tamoxifen (10-fold) or 4-OH tamoxifen (>1000-fold) retains complete sensitivity to ERA-923 . In preclinical models, ERA-923 has an imp... | |||
T71010 |
Norendoxifen
|
||
Norendoxifen, also known as 4-hydroxy-N, N-didesmethyltamoxifen, is a nonsteroidal aromatase inhibitor of the triphenylethylene group that was never marketed. It is an active metabolite of the selective estrogen receptor modulator tamoxifen. | |||
T25888 |
NSC-670224
NSC 670224 |
||
NSC-670224 is an inhibitor of histone deacetylases-6 (HDAC6) and nuclear factor-κB (NF-κB) activation blocker. It has been shown to be toxic to Saccharomyces cerevisiae at low micromolar concentrations, potentially acts via a mechanism of action related t | |||
T74457 | EGFR-IN-42 | ||
EGFR-IN-42 (Compound 17b) 是一种有效的 EGFR 抑制剂,具有单位数纳摩尔活性。EGFR-IN-42 通过共价键将他莫昔芬或安多昔芬与 EGFR 抑制剂吉非替尼连接起来。EGFR-IN-42 保留 ER 拮抗剂活性和 EGFR 抑制作用。EGFR-IN-42 具有优越的抗癌活性。 | |||
T74458 | EGFR-IN-43 | ||
EGFR-IN-43 (Compound 17c) 是一种有效的EGFR 抑制剂,具有单位数纳摩尔活性。EGFR-IN-43 通过共价键将他莫昔芬或安多昔芬与EGFR 抑制剂吉非替尼连接起来。EGFR-IN-43 保留 ER 拮抗剂活性和EGFR 抑制作用。EGFR-IN-43 具有优越的抗癌活性。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T3855 |
Tracheloside
|
Estrogen Receptor/ERR; Phosphorylase | Endocrinology/Hormones; Metabolism |
Tracheloside 是抗雌激素木质素,利用 ERK1/2 刺激促进角质形成细胞增殖,是一种良好的促进伤口愈合的药物。 | |||
TN4731 |
Pachyaximine A
|
Antifection | Microbiology/Virology |
Pachyaximine A possesses significant antibacterial activity against Escherichia coli, Staphylococcus aureus, Corynebacterium diphtheriae and Corynebacterium pyrogenes. (-)-Pachyaximine A demonstrates significant activity as antiestrogen binding site (AEBS |